VolitionRx prices $6 million public offering of common stock and warrants
PositiveFinancial Markets

VolitionRx has successfully priced a public offering of common stock and warrants, raising $6 million. This move is significant as it allows the company to bolster its financial position and invest in future growth opportunities. The funds raised will likely enhance VolitionRx's ability to innovate and expand its operations, which is promising for investors and stakeholders alike.
— Curated by the World Pulse Now AI Editorial System